Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Learning to manage pills could save your kidneys

NCT ID NCT07622134

Prevention Sponsor: Nakhon Pathom Rajabhat University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests an 8-week health literacy program designed to help people aged 55-74 who take 5 or more medications daily. The goal is to see if the program improves their understanding of medication management and reduces their risk of developing chronic kidney disease. Half of the 104 participants will receive the program, while the other half gets standard care. Researchers will measure changes in health literacy, kidney function, and prevention behaviors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Health Literacy Promotion Program (HLP-CKD) - an 8-week behavioral program with education and skill-building
What this could lead to
If it works, this could offer a simple, low-cost way to help people on multiple medications reduce their risk of chronic kidney disease.
What could go wrong
This is a small, early-stage trial (104 people) testing a behavioral program, not a drug. Results may not be dramatic or widely applicable, and improvements in health literacy may not translate to actual kidney protection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 104 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 to 74 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 55-74 years diagnosed with non-communicable diseases. * Currently taking 5 or more medications daily (Polypharmacy) for at least 6 months. * Have at least one risk factor for chronic kidney disease (e.g., Hypertension or Diabetes). * Able to communicate, read, and write in Thai. * Willing to participate in the 8-week program and follow-up assessments. Exclusion Criteria: * Patients already diagnosed with Chronic Kidney Disease (CKD) stage 3 - 5. * Having severe cognitive impairment or psychiatric disorders that prevent participation. * Having severe complications or being in an unstable clinical condition. * Planning to move out of the study area during the 12-week study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome chronic kidney disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney diseases Health literacy Polypharmacy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Health Promoting Hospital

    Nakhon Pathom, Changwat Nakhon Pathom, 73000, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.